Labopharm Gets January Action Date For Once-Daily Tramadol
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA accepts additional data submitted in response to May 2007 “approvable” letter.
You may also be interested in...
Labopharm Submits Complete Response For Tramadol
Canadian specialty pharma now awaits new action date for delayed once-daily analgesic, already launched in 12 other countries.
Labopharm Tramadol-Acetaminophen Combo Could Offer Twice-Daily Dosing
Canadian firm initiates Phase III trial evaluating the combination for treatment of acute low back pain.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.